ADAM17 and COVID-19: Furthermore, although a genetic predisposition to elevated circulating ADAM-17 levels is associated with severe COVID-19 [18], and ADAM-17 inhibition in mice has been shown to offer a protective role against morbidity, lung injury, and inflammation upon SARS-CoV-2 infection [17], further human studies are needed.